Literature DB >> 23647757

The radiosensitization effect of titanate nanotubes as a new tool in radiation therapy for glioblastoma: a proof-of-concept.

C Mirjolet1, A L Papa, G Créhange, O Raguin, C Seignez, C Paul, G Truc, P Maingon, N Millot.   

Abstract

BACKGROUND AND
PURPOSE: One of the new challenges to improve radiotherapy is to increase the ionizing effect by using nanoparticles. The interest of titanate nanotubes (TiONts) associated with radiotherapy was evaluated in two human glioblastoma cell lines (SNB-19 and U87MG).
MATERIALS AND METHODS: Titanate nanotubes were synthetized by the hydrothermal treatment of titanium dioxide powder in a strongly basic NaOH solution. The cytotoxicity of TiONts was evaluated on SNB-19 and U87MG cell lines by cell proliferation assay. The internalization of TiONts was studied using Transmission Electron Microscopy (TEM). Finally, the effect of TiONts on cell radiosensitivity was evaluated using clonogenic assay. Cell cycle distribution was evaluated by flow cytometry after DNA labeling. DNA double-stranded breaks were evaluated using γH2AX labeling.
RESULTS: Cells internalized TiONts through the possible combination of endocytosis and diffusion with no cytotoxicity. Clonogenic assays showed that cell lines incubated with TiONts were radiosensitized with a decrease in the SF2 parameter for both SNB-19 and U87MG cells. TiONts decreased DNA repair efficiency after irradiation and amplified G2/M cell-cycle arrest.
CONCLUSION: Our results indicated that further development of TiONts might provide a new useful tool for research and clinical therapy in the field of oncology.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cytotoxicity; Glioblastoma; Internalization; Radiosensitization; Titanate nanotubes

Mesh:

Substances:

Year:  2013        PMID: 23647757     DOI: 10.1016/j.radonc.2013.04.004

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  18 in total

1.  In silico studies of interactions of peptide-conjugated cholesterol metabolites and betulinic acid with EGFR, LDR, and N-terminal fragment of CCKA receptors.

Authors:  Madeline M Bashant; Saige M Mitchell; Lucy R Hart; Charlotta G Lebedenko; Ipsita A Banerjee
Journal:  J Mol Model       Date:  2021-12-28       Impact factor: 1.810

Review 2.  The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies.

Authors:  Semer Maksoud
Journal:  Mol Neurobiol       Date:  2022-06-13       Impact factor: 5.682

Review 3.  Nanoparticles for Radiation Therapy Enhancement: the Key Parameters.

Authors:  Paul Retif; Sophie Pinel; Magali Toussaint; Céline Frochot; Rima Chouikrat; Thierry Bastogne; Muriel Barberi-Heyob
Journal:  Theranostics       Date:  2015-06-11       Impact factor: 11.556

Review 4.  The potential effectiveness of nanoparticles as radio sensitizers for radiotherapy.

Authors:  Mohammad Babaei; Maryam Ganjalikhani
Journal:  Bioimpacts       Date:  2014-03-08

5.  Docetaxel-titanate nanotubes enhance radiosensitivity in an androgen-independent prostate cancer model.

Authors:  Céline Mirjolet; Julien Boudon; Alexis Loiseau; Sandy Chevrier; Romain Boidot; Alexandra Oudot; Bertrand Collin; Etienne Martin; Pattayil Alias Joy; Nadine Millot; Gilles Créhange
Journal:  Int J Nanomedicine       Date:  2017-08-30

6.  Titanium Dioxide Nanoparticles as Radiosensitisers: An In vitro and Phantom-Based Study.

Authors:  Esho Qasho Youkhana; Bryce Feltis; Anton Blencowe; Moshi Geso
Journal:  Int J Med Sci       Date:  2017-05-15       Impact factor: 3.738

Review 7.  Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.

Authors:  Ewelina Piktel; Katarzyna Niemirowicz; Marzena Wątek; Tomasz Wollny; Piotr Deptuła; Robert Bucki
Journal:  J Nanobiotechnology       Date:  2016-05-26       Impact factor: 10.435

Review 8.  Standards and Methodologies for Characterizing Radiobiological Impact of High-Z Nanoparticles.

Authors:  Anna Subiel; Reece Ashmore; Giuseppe Schettino
Journal:  Theranostics       Date:  2016-06-20       Impact factor: 11.556

9.  Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells.

Authors:  Ping-Hsiu Wu; Yasuhito Onodera; Yuki Ichikawa; Erinn B Rankin; Amato J Giaccia; Yuko Watanabe; Wei Qian; Takayuki Hashimoto; Hiroki Shirato; Jin-Min Nam
Journal:  Int J Nanomedicine       Date:  2017-07-14

Review 10.  Metal-based NanoEnhancers for Future Radiotherapy: Radiosensitizing and Synergistic Effects on Tumor Cells.

Authors:  Yan Liu; Pengcheng Zhang; Feifei Li; Xiaodong Jin; Jin Li; Weiqiang Chen; Qiang Li
Journal:  Theranostics       Date:  2018-02-12       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.